BSECompany Update20h ago · 30 Oct 2026, 06:46 pm

Investor Presentation for the quarter and half year ended September 30, 2026.

Narayana Hrudayalaya Ltd · 539551

✦ AI Summary▲ PositiveResults

Narayana Hrudayalaya Ltd has released its investor presentation for the quarter and half year ended September 30, 2026, highlighting a 73.0% YoY increase in consolidated operating revenues to ₹ 28,440 Mn and a 21.3% EBITDA margin.

Analysis Scores

Earnings Impact8/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact9/10
Market Sentiment8/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Narayana Hrudayalaya Ltd - 539551 - Announcement under Regulation 30 (LODR)-Investor Presentation

Attachments (1)

📄

68c208cc-c3ab-4cd7-b2f7-40a6a5d6efd1.pdf

pdf

Download →
View document text
Date of submission: October 30, 2026 To, To, The Secretary The Secretary Listing Department Listing Department BSE Limited National Stock Exchange of India Limited Department of Corporate Services Exchange Plaza, Bandra Kurla Complex Phiroze Jeejeebhoy Towers, Mumbai – 400 051 Dalal Street, Mumbai – 400 001 Scrip Code- NH Scrip Code – 539551 (EQ), 975516 & 976418 Dear Sir/Madam, Sub: Investor Presentation for the quarter and half year ended September 30, 2026. With reference to the subject, please find enclosed the Investor Presentation for the quarter and half year ended September 30, 2026 Kindly take the above information on record. Thanking you Yours faithfully For Narayana Hrudayalaya Limited Sridhar S. Group Company Secretary, Legal & Compliance Officer Encl.: as above Earnings Update Q2 FY27 Topic Slide No. Our Footprint 03 Narayana Health at a Glance 04 Q2 FY27 Highlights 05 Index Capex 16 Digital Initiatives 17 Narayana Health ESG Vision – “Health For All” 18 Shareholding Pattern 19 Our Footprint (as on 1st October 2026) United Kingdom India Ophthalmology Centers Hospitals/ Surgical Centers Diagnostic Centers Hospitals/Surgical Centers + Delhi NCR Urgent Treatment Centers Barlborough Jaipur Rochdale Guwahati Lincolnshire Birmingham Buckinghamshire Ahmedabad Jamshedpur Emersons Devizes Ilford Raipur Kolkata Green Gillingham Shepton Mallet Southampton Mumbai Portsmouth Plymouth Davanagere Cayman Islands Shimoga Bengaluru Mysore Health City Camana Bay Health City Cayman Islands Narayana Health – At a Glance Total Capacity Beds 6,374 Facility Details No. of Facilities Operational Beds South (India) Hospitals - 7 | Heart Centres - 2| Clinics -15 | Diagnostic Centre - 1 India – Hospitals and Heart Centres 21 5,624 Operational Beds - 2,159 (Hospitals) and 132 (HC) East (India) India - Clinics and Dialysis Centres (1) 20 0 Hospitals - 7 | Clinics - 3| Dialysis Centre - 1 Operational beds - 2,121 Cayman Islands 2 165 North (India) Hospitals – 3 United Kingdom 13 330 Operational beds: 838 West (India) Healthcare Facilities 56 6,119 Hospitals - 2 Operational beds - 374 (1)This includes 12 (Twelve) Integrated Care Clinics as on 30th Sep 2026. Total Staff ~21,150 (2)Banashankari Hospital and Nagarabhavi Clinic commenced operations in the last week of Clinical : ~ 13,100 Sep'26; operating metrics will be reflected from Q3 FY27. Non-clinical : ~ 8,050 Key Highlights – Operational & Financial Performance (Q2 FY27) ▪ Narayana Institute of Cardiac Sciences, Bengaluru has performed : • South India’s first Percutaneous Transcatheter Tricuspid Valve Replacement (TTVR) • India’s first Transcatheter Tricuspid Valve Implantation (TTVI) on a 14-year-old • 54 TAVIs and 6 hybrid percutaneous pulmonary valve implantations in Q2 FY 27 • Highest volume of cardiac surgeries cases in a single day: 38 cases. ▪ NH Mumbai successfully managed • Complex surgical management of a newborn presented with sternal cleft, a very rare condition. Clinical & ▪ NH RTIICS achieved: Operational • Multidisciplinary surgery for spindle cell sarcoma of the adnexa with extensive IVC tumor thrombus extending into the right atrium • Robotic-assisted resection of Type B3 thymoma with phrenic nerve invasion in a patient with myasthenia gravis. ▪ Consolidated operating revenues of ₹ 28,440 Mn in Q2 FY27, a change of +73.0% YoY and +6.0% QoQ. ▪ Consolidated EBITDA of ₹ 6,054 Mn in Q2 FY27 at a margin of 21.3%. Consolidated PAT of ₹ 3,012 Mn for Q2 FY27 at a margin of 10.6%. Financial ▪ Consolidated Total Borrowings less Cash & Bank Balance and Investments of ₹ 18,830 Mn as on 30th Performance September 2026, i.e., net debt to equity ratio of 0.38 (Out of which, debt worth US $114 Mn and GBP £150 Mn are foreign currency denominated). India Operations – Revenue (Q2 FY27) ₹ Mn Total* Domestic 14,000 13,442 20,004 13,500 C 186 14,388 13,000 13,196 12,552 15,004 12,331 12,500 C 171 9.0% QoQ 11,863 10,004 12,000 C 156 H 13,256 11,500 H 12,381 5,004 11,000 H 11,707 4 10,500 Q2 FY26 Q1 FY27 Q2 FY27 Q2 FY26 Q1 FY27 Q2 FY27 16.7% YoY H - Hospitals C - Clinics International YTD Gross Written Premium** 1,000 901 900 505 700 405 341 41.2% QoQ Q2 FY26 Q1 FY27 Q2 FY27 FY26 FY27 75.7% YoY *Total revenue is excluding ATHMA, Medha and adjusted with Inter Company eliminations 6 ** Gross written premium of NH Insurance. The YTD numbers are starting from 1st April of the financial year to the reporting quarters. 6 India Hospital – Revenue Mix (Q2 FY27) Business Mix(4,7) Specialty-Profile(4,7) Payor-Profile(4,7) 25% 33% 18% Cardiac Sciences Medicine and GI sciences Owned Hospitals(1) Oncology Domestic Walk-in patients Operated Hospitals Renal Sciences Insured Patients (5) Neuro Sciences Heart Centres Schemes (6) Orthopaedics Clinic Business Others International patients (1) NH owns on freehold basis and operates with the P&L responsibility (5) Insured Patients include Insurance-covered patients, corporate patients (including PSU’s on hospital tariff) (2) NH operates the hospitals on rental/revenue sharing basis and owns the P&L responsibility (6) Schemes include CGHS, ESIS, other state government schemes (3) Includes clinics and dialysis centres excl. NHIC (7) Percentages might not add up to 100% due to rounding off (4) As percentage of operating revenue, excluding NHIC India Hospitals – Operations Review (Q2 FY27) ALOS Average Revenue Per Patient (IP & OP) (1,2) Days ₹ ‘000 162.6 163.4 149.4 4.3 4.3 4.3 4.8 5.1 5.2 Q2 FY26 Q1 FY27 Q2 FY27 Q2 FY26 Q1 FY27 Q2 FY27 Patient Footfalls (IP & OP)(1,3) ICU Occupied Bed Days ‘000 800 81 ‘000 700 64 67 100 96 96 662 674 80 58 57 60 Q2 FY26 Q1 FY27 Q2 FY27 Q2 FY26 Q1 FY27 Q2 FY27 Hospitals OP Clinics OP IP (1) OP figures include day-care business. Clinics OP pertains to footfalls related to NHIC. (2) ARPOB for the period Q2 FY27 was ₹ 19.5 Mn as against ₹ 17.5 Mn in Q2 FY26. 8 (3) Footfalls for IP correspond to Discharges. 8 India Hospitals – Cluster Split (Q2 FY27) This considers owned/operated hospitals & heart centers in India Southern Eastern Bangalore Kolkata Western Northern Peripheral Peripheral Regions • NICS • Mysore • RTIICS • Jamshedpur • Mumbai • Gurugram • MSMC • Shimoga • Barasat • Guwahati • Ahmedabad • New Delhi • HSR • Davangere • NMH • Raipur • Jaipur • Dharwad • NSH • Kolar Capacity Beds 1490 800 1453 745 405 882 % of Hospital Operating 37% 9% 26% 10% 5% 13% Revenues YoY Revenue Growth 18% 10% 16% 16% -1 22 %% 12% YoY Hospital 7% 1% 2% 6% 22%% 5% Discharges 2% OP ARPP(1) 6.1 4.3 4.6 4.4 4.3 5.3 (₹ ‘000) 5.0 3.7 4.5 4.1 4.3 4.6 IP ARPP 251 88 169 145 130 126 (₹ ‘000) 198.3 67.9 121.4 114.7 128.3 (1) OP ARPP includes day care. 9 India Hospitals – Profitability Snapshot (Q2 FY27) Includes NH India Hospitals 5,0E0B0ITDA and EBITDA Margin (1) Cost Structure 4,5₹0 ‘0Mn % of Operating Revenues Chart Title 26.8% Rental / Revenue Share (7) 4,000 2% 2% 2% 3,500 24.8% (1) 100% 26.0% (2) 23.8% 11% 10% 10% 3,000 90% 23.4% (2) 80% 2,500 22.5% (2) 17% (5) 17% 18% 2,000 60% (1) 3,799 3,229 50% 23% (3) 23% 22% 1,500 2,903 1,000 30% 27% 28% 26% - 0% Q2 FY26 Q1 FY27 Q2 FY27 Q2 FY26 Q1 FY27 Q2 FY27 Doctors and Nurses(4) Consumable Expenses(5) Other Expenses(6) Other Manpower Cost 1) Denotes EBITDA and EBITDA% of India Hospitals 5) Doctors and Nurses = Employee benefits + Professional fees to doctors 2) Denotes EBITDA% of India Hospitals and NHIC Clinics together 6) Consumable Expenses = Purchase of medical consumables, drugs and surgical equipment 3) EBITDA of NH India for Q2 FY27 stood at ₹ 3,548 Mn (24.6%) net of changes in inventories of medical consumables, drugs and surgical equipment 4) EBITDA (excluding other income) of NH India Hospitals for Q2 FY27 is 23.6%; Q1 FY27: 7) Other Expenses = Overhead expenses + All other expenses 22.3%; Q2 FY26: 22.2% 8) Effect of IND AS benefits is not considered 10 India Insurance – Key Financial Summary ₹ Mn Financial Parameters Q2 FY27 Q2 FY26 Gross Written Premium 78 70 Reinsurance Premium -3 -3 Net Written Premium 75 67 Change [Showing first 8,000 characters — download PDF for full document]